$PDLI PDL BIOPHARMA, INC. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in PDL BIOPHARMA, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in PDL BIOPHARMA, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in PDL BIOPHARMA, INC. for free.

CIK Number: 0000882104
IRS Number: 943023969
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: PDLI
Company Address: 59 DAMONTE RANCH PARKWAY SUITE B-375 RENO 89521
Former name: PROTEIN DESIGN LABS INC/DE, date of change: 1993-03-28

Market Capitalization: $367.50M
Prev close: $2.21
Average Daily Volume: 2,845,720
Days Low: $2.15
Year Low: $1.93
Year High: $3.84

PDL BIOPHARMA, INC. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 04 2021PDLIPDL BIOPHARMA, INC ...Silver Point Capital L.P.10% OwnerBuyP2.506,325,21315,813,03323,783,27317.5 M to 23.8 M (+36.23 %)
Dec 31 2020PDLIPDL BIOPHARMA, INC ...GRYSKA DAVID WDirectorSellS2.7420,00054,8001,38721.4 K to 1.4 K (-93.51 %)
Dec 29 2020PDLIPDL BIOPHARMA, INC ...Silver Point Capital L.P.10% OwnerBuyP2.69268,600722,53417,458,06017.2 M to 17.5 M (+1.56 %)
Dec 29 2020PDLIPDL BIOPHARMA, INC ...Silver Point Capital L.P.10% OwnerBuyP2.70235,000634,50017,189,46017 M to 17.2 M (+1.39 %)
Dec 29 2020PDLIPDL BIOPHARMA, INC ...Silver Point Capital L.P.10% OwnerBuyP2.65128,000339,20016,954,46016.8 M to 17 M (+0.76 %)
Dec 23 2020PDLIPDL BIOPHARMA, INC ...Silver Point Capital L.P.10% OwnerBuyP2.60485,0001,261,00016,826,46016.3 M to 16.8 M (+2.97 %)
Dec 23 2020PDLIPDL BIOPHARMA, INC ...Silver Point Capital L.P.10% OwnerBuyP2.59850,0002,201,50016,341,46015.5 M to 16.3 M (+5.49 %)
Dec 23 2020PDLIPDL BIOPHARMA, INC ...Silver Point Capital L.P.10% OwnerBuyP2.63230,000604,90015,491,46015.3 M to 15.5 M (+1.51 %)
Dec 22 2020PDLIPDL BIOPHARMA, INC ...MCLAUGHLIN JOHN PETERDirectorSellS2.61277,934724,574200,000477.9 K to 200 K (-58.15 %)
Dec 22 2020PDLIPDL BIOPHARMA, INC ...MCLAUGHLIN JOHN PETERDirectorSellS2.6250,000131,200477,934527.9 K to 477.9 K (-9.47 %)
Dec 18 2020PDLIPDL BIOPHARMA, INC ...Silver Point Capital L.P.10% OwnerBuyP2.61398,0001,038,78015,261,46014.9 M to 15.3 M (+2.68 %)
Dec 18 2020PDLIPDL BIOPHARMA, INC ...Silver Point Capital L.P.10% OwnerBuyP2.581,350,0003,483,00014,863,46013.5 M to 14.9 M (+9.99 %)
Dec 17 2020PDLIPDL BIOPHARMA, INC ...Stone Christopher LewisVP, Gen. Counsel & ...SellS2.56200,000512,000405,559605.6 K to 405.6 K (-33.03 %)
Dec 17 2020PDLIPDL BIOPHARMA, INC ...Monnet DominiquePresident and CEOSellS2.60500,0001,300,000734,9211.2 M to 734.9 K (-40.49 %)
Dec 17 2020PDLIPDL BIOPHARMA, INC ...Stone Christopher LewisVP, Gen. Counsel & ...SellS2.56200,000512,000405,559605.6 K to 405.6 K (-33.03 %)

View all PDL BIOPHARMA, INC. insider transactions.